{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Cryptosporidium", "nitazoxanide", "octaarginine"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35745507", "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "06", "Day": "06"}], "Language": ["eng"], "ELocationID": ["653", "10.3390/pathogens11060653"], "Journal": {"ISSN": "2076-0817", "JournalIssue": {"Volume": "11", "Issue": "6", "PubDate": {"Year": "2022", "Month": "Jun", "Day": "06"}}, "Title": "Pathogens (Basel, Switzerland)", "ISOAbbreviation": "Pathogens"}, "ArticleTitle": "Octaarginine Improves the Efficacy of Nitazoxanide against <i>Cryptosporidium parvum</i>.", "Abstract": {"AbstractText": ["Cryptosporidiosis is an intestinal disease that affects a variety of hosts including animals and humans. Since no vaccines exist against the disease till date, drug treatment is the mainstay of disease control. Nitazoxanide (NTZ) is the only FDA-approved drug for the treatment of human cryptosporidiosis. However, its efficacy in immunocompromised people such as those with AIDS, in malnourished children, or those with concomitant cryptosporidiosis is limited. In the absence of effective drugs against cryptosporidiosis, improving the efficacy of existing drugs may offer an attractive alternative. In the present work, we have assessed the potential of the cell-penetrating peptide (CPP) octaarginine (R8) to increase the uptake of NTZ. Octaarginine (R8) was synthetically attached to NTZ in an enzymatically releasable manner and used to inhibit growth of <i>Cryptosporidium parvum</i> in an in vitro culture system using human ileocecal adenocarcinoma (HCT-8) cell line. We observed a significant concentration-dependent increase in drug efficacy. We conclude that coupling of octaarginine to NTZ is beneficial for drug activity and it represents an attractive strategy to widen the repertoire of anti-cryptosporidial therapeutics. Further investigations such as in vivo studies with the conjugate drug will help to further characterize this strategy for the treatment of cryptosporidiosis."]}, "AuthorList": [{"Identifier": ["0000-0002-8933-6349"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Infectious Medicine, Institute of Parasitology, Faculty of Veterinary Medicine, University of Leipzig, 04103 Leipzig, Germany."}, {"Identifier": [], "Affiliation": "Department of Veterinary Medicine, College of Agriculture, Can Tho University, Can Tho 900000, Vietnam."}], "LastName": "Nguyen-Ho-Bao", "ForeName": "Tran", "Initials": "T"}, {"Identifier": ["0000-0002-9695-7645"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory for Molecular Parasitology, Department of Microbiology and Parasitology, University of Buea, Buea P.O. Box 63, Cameroon."}, {"Identifier": [], "Affiliation": "Centre for Research on Health and Priority Pathologies, Institute of Medical Research and Medicinal Plants Studies (IMPM), Yaound\u00e9 P.O Box 13033, Cameroon."}], "LastName": "Ambe", "ForeName": "Lum A", "Initials": "LA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Infectious Medicine, Institute of Parasitology, Faculty of Veterinary Medicine, University of Leipzig, 04103 Leipzig, Germany."}], "LastName": "Berberich", "ForeName": "Maxi", "Initials": "M"}, {"Identifier": ["0000-0003-4550-8492"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biomedical Research Center Seltersberg (BFS), Institute of Parasitology, Justus Liebig University Giessen, 35392 Giessen, Germany."}], "LastName": "Hermosilla", "ForeName": "Carlos", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biomedical Research Center Seltersberg (BFS), Institute of Parasitology, Justus Liebig University Giessen, 35392 Giessen, Germany."}], "LastName": "Taubert", "ForeName": "Anja", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Infectious Medicine, Institute of Parasitology, Faculty of Veterinary Medicine, University of Leipzig, 04103 Leipzig, Germany."}], "LastName": "Daugschies", "ForeName": "Arwid", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Infectious Medicine, Institute of Parasitology, Faculty of Veterinary Medicine, University of Leipzig, 04103 Leipzig, Germany."}, {"Identifier": [], "Affiliation": "Laboratory for Molecular Parasitology, Department of Microbiology and Parasitology, University of Buea, Buea P.O. Box 63, Cameroon."}], "LastName": "Kamena", "ForeName": "Faustin", "Initials": "F"}], "GrantList": [{"GrantID": "Project 911", "Agency": "Doctoral scholarship of the vietnamese Governement", "Country": ""}, {"GrantID": "01DG20023", "Agency": "German Federal Ministry of Research and Education (BMBF) grant", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pathogens", "NlmUniqueID": "101596317", "ISSNLinking": "2076-0817"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Leitch G.J., He Q. Cryptosporidiosis-an overview. J. Biomed. Res. 2011;25:1\u201316. doi: 10.1016/S1674-8301(11)60001-8.", "ArticleIdList": ["10.1016/S1674-8301(11)60001-8", "PMC3368497", "22685452"]}, {"Citation": "Raj Mainali N., Quinlan P., Ukaigwe A., Amirishetty S. Cryptosporidial diarrhea in an immunocompetent adult: Role of nitazoxanide. J. Community Hosp. Intern. Med. Perspect. 2013;3:21075. doi: 10.3402/jchimp.v3i3-4.21075.", "ArticleIdList": ["10.3402/jchimp.v3i3-4.21075", "PMC3879510", "24392210"]}, {"Citation": "Ventura G., Cauda R., Larocca L.M., Riccioni M.E., Tumbarello M., Lucia M.B. Gastric cryptosporidiosis complicating HIV infection: Case report and review of the literature. Eur. J. Gastroenterol. Hepatol. 1997;9:307\u2013310. doi: 10.1097/00042737-199703000-00017.", "ArticleIdList": ["10.1097/00042737-199703000-00017", "9096436"]}, {"Citation": "Kotloff K.L., Nataro J.P., Blackwelder W.C., Nasrin D., Farag T.H., Panchalingam S., Wu Y., Sow S.O., Sur D., Breiman R.F., et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): A prospective, case-control study. Lancet. 2013;382:209\u2013222. doi: 10.1016/S0140-6736(13)60844-2.", "ArticleIdList": ["10.1016/S0140-6736(13)60844-2", "23680352"]}, {"Citation": "Miao Y.M., Gazzard B.G. Management of protozoal diarrhoea in H1V disease. HIV Med. 2000;1:194\u2013199. doi: 10.1046/j.1468-1293.2000.00028.x.", "ArticleIdList": ["10.1046/j.1468-1293.2000.00028.x", "11737348"]}, {"Citation": "Ives N.J., Gazzard B.G., Easterbrook P.J. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART) in London clinic. J. Infect. 2001;42:134\u2013139. doi: 10.1053/jinf.2001.0810.", "ArticleIdList": ["10.1053/jinf.2001.0810", "11531320"]}, {"Citation": "Adesiji Y.O., Lawal R.O., Taiwo S.S., Fayemiwo S.A., Adeyeba O.A. Cryptosporidiosis in HIV infected patients with diarrhoea in Osun State Southwestern Nigeria. Eur. J. Gen. Med. 2007;4:119\u2013122. doi: 10.29333/ejgm/82505.", "ArticleIdList": ["10.29333/ejgm/82505"]}, {"Citation": "Amadi B., Mwiya M., Sianongo S., Payne L., Watuka A., Katubulushi M., Kelly P. High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: A randomised controlled trial. BMC Infect. Dis. 2009;9:195. doi: 10.1186/1471-2334-9-195.", "ArticleIdList": ["10.1186/1471-2334-9-195", "PMC2794874", "19954529"]}, {"Citation": "Kamena F., Monnanda B., Makou D., Capone S., Patora-Komisarska K., Seebach D. On the mechanism of eukaryotic cell penetration by \u03b1- And \u03b2-oligoarginines-Targeting infected erythrocytes. Chem. Biodivers. 2011;8:1\u201312. doi: 10.1002/cbdv.201000318.", "ArticleIdList": ["10.1002/cbdv.201000318", "21259419"]}, {"Citation": "Sparr C., Purkayastha N., Kolesinska B., Gengenbacher M., Amulic B., Matuschewski K., Seebach D., Kamena F. Improved Efficacy of Fosmidomycin against Plasmodium and Mycobacterium Species by Combination with the Cell-Penetrating. Antimicrob. Agents Chemother. 2013;57:4689\u20134698. doi: 10.1128/AAC.00427-13.", "ArticleIdList": ["10.1128/AAC.00427-13", "PMC3811453", "23856773"]}, {"Citation": "Nguyen-Ho-Bao T., Berberich M., Zheng W., Seebach D., Daugschies A., Kamena F. A simple and efficient transfection protocol for Cryptosporidium parvum using Polyethylenimine (PEI) and Octaarginine. Parasitology. 2020;147:1065\u20131070. doi: 10.1017/S0031182020000724.", "ArticleIdList": ["10.1017/S0031182020000724", "PMC10317764", "32364095"]}, {"Citation": "Cabada M., White A.J. Treatment of cryptosporidiosis: Do we know what we think we know? Curr. Opin. Infect. Dis. 2010;5:494\u2013499. doi: 10.1097/QCO.0b013e32833de052.", "ArticleIdList": ["10.1097/QCO.0b013e32833de052", "20689422"]}, {"Citation": "Mead J.R., Arrowood M.J. Treatment of Cryptosporidiosis. Parasite Dis. 2014:455\u2013486. doi: 10.1007/978-3-7091-1562-6_11.", "ArticleIdList": ["10.1007/978-3-7091-1562-6_11"]}, {"Citation": "Manjunatha U.H., Vinayak S., Zambriski J.A., Chao A.T., Sy T., Noble C.G., Bonamy G., Kondreddi R.R., Zou B., Gedeck P., et al. A Cryptosporidium PI (4) K inhibitor is a drug candidate for cryptosporidiosis. Nature. 2017;546:376\u2013380. doi: 10.1038/nature22337.", "ArticleIdList": ["10.1038/nature22337", "PMC5473467", "28562588"]}, {"Citation": "Fox L.M., Saravolatz L.D. Nitazoxanide: A New Thiazolide Antiparasitic Agent. Clin. Infect. Dis. 2005;40:1173\u20131180. doi: 10.1086/428839.", "ArticleIdList": ["10.1086/428839", "15791519"]}, {"Citation": "Stalmans S., Bracke N., Wynendaele E., Gevaert B., Peremans K., Burvenich C., Polis I., De Spiegeleer B. Cell-penetrating peptides selectively cross the blood-brain barrier in vivo. PLoS ONE. 2015;10:e0139652. doi: 10.1371/journal.pone.0139652.", "ArticleIdList": ["10.1371/journal.pone.0139652", "PMC4605843", "26465925"]}, {"Citation": "Seebach D., Namoto K., Mahajan Y.R., Bindsch\u00e4dler P., Sustmann R., Kirsch M., Ryder N.S., Weiss M., Sauer M., Roth C., et al. Chemical and biological investigations of \u03b2-oligoarginines. Chem. Biodivers. 2004;1:65\u201397. doi: 10.1002/cbdv.200490014.", "ArticleIdList": ["10.1002/cbdv.200490014", "17191776"]}, {"Citation": "Kristensen M., Birch D., Nielsen H.M. Applications and challenges for use of cell-penetrating peptides as delivery vectors for peptide and protein cargos. Int. J. Mol. Sci. 2016;17:185. doi: 10.3390/ijms17020185.", "ArticleIdList": ["10.3390/ijms17020185", "PMC4783919", "26840305"]}, {"Citation": "Griffiths J.K., Balakrishnan R., Widmer G., Tzipori S. Paromomycin and geneticin inhibit intracellular Cryptosporidium parvum without trafficking through the host cell cytoplasm: Implications for drug delivery. Infect. Immun. 1998;66:3874\u20133883. doi: 10.1128/IAI.66.8.3874-3883.1998.", "ArticleIdList": ["10.1128/IAI.66.8.3874-3883.1998", "PMC108441", "9673275"]}, {"Citation": "Bouzid M., Hunter P.R., Chalmers R.M., Tyler K.M. Cryptosporidium pathogenicity and virulence. Clin. Microbiol. Rev. 2013;26:115\u2013134. doi: 10.1128/CMR.00076-12.", "ArticleIdList": ["10.1128/CMR.00076-12", "PMC3553671", "23297262"]}, {"Citation": "Theodos C.M., Griffiths J.K., D\u2019onfro J., Fairfield A., Tzipori S. Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models. Antimicrob. Agents Chemother. 1998;42:1959\u20131965. doi: 10.1128/AAC.42.8.1959.", "ArticleIdList": ["10.1128/AAC.42.8.1959", "PMC105716", "9687390"]}, {"Citation": "Chen X.M., O\u2019Hara S.P., Huang B.Q., Splinter P.L., Nelson J.B., LaRusso N.F. Localized glucose and water influx facilitates Cryptosporidium parvum cellular invasion by means of modulation of host-cell membrane protrusion. Proc. Natl. Acad. Sci. USA. 2005;102:6338\u20136343. doi: 10.1073/pnas.0408563102.", "ArticleIdList": ["10.1073/pnas.0408563102", "PMC1088355", "15851691"]}, {"Citation": "Shahiduzzaman M., Dyachenko V., Obwaller A., Unglaube S., Daugschies A. Combination of cell culture and quantitative PCR for screening of drugs against Cryptosporidium parvum. Vet Parasitol. 2009;162:271\u2013277. doi: 10.1016/j.vetpar.2009.03.009.", "ArticleIdList": ["10.1016/j.vetpar.2009.03.009", "19342176"]}, {"Citation": "Koziolek M., Alcaro S., Augustijns P., Basit A.W., Grimm M., Hens B., Hoad C.L., Jedamzik P., Madla C.M., Maliepaard M., et al. The mechanisms of pharmacokinetic food-drug interactions\u2013A perspective from the UNGAP group. Eur. J. Pharm. Sci. 2019;134:31\u201359. doi: 10.1016/j.ejps.2019.04.003.", "ArticleIdList": ["10.1016/j.ejps.2019.04.003", "30974173"]}, {"Citation": "Sonzogni-Desautels K., Renteria Flores A., Vasquez Camargo F., Di Lenardo T.Z., Mikhail A., Arrowood M.J., Fortin A., Ndao M. Oleylphosphocholine (OlPC) arrests Cryptosporidium parvum growth in vitro and prevents lethal infection in interferon gamma receptor knock-out mice. Front. Microbiol. 2015;6:973. doi: 10.3389/fmicb.2015.00973.", "ArticleIdList": ["10.3389/fmicb.2015.00973", "PMC4585137", "26441906"]}, {"Citation": "Najdrowski M., Heckeroth A.R., Wackwitz C., Gawlowska S., Mackenstedt U., Kliemt D., Daugschies A. Development and validation of a cell culture based assay for in vitro assessment of anticryptosporidial compounds. Parasitol. Res. 2007;101:161\u2013167. doi: 10.1007/s00436-006-0437-z.", "ArticleIdList": ["10.1007/s00436-006-0437-z", "17216237"]}, {"Citation": "Zhang H., Zhu G. Quantitative RT-PCR assay for high-throughput screening (HTS) of drugs against the growth of Cryptosporidium parvum in vitro. Front. Microbiol. 2015;6:991. doi: 10.3389/fmicb.2015.00991.", "ArticleIdList": ["10.3389/fmicb.2015.00991", "PMC4585199", "26441920"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "5", "Day": "3"}, {"Year": "2022", "Month": "5", "Day": "31"}, {"Year": "2022", "Month": "6", "Day": "1"}, {"Year": "2022", "Month": "6", "Day": "24", "Hour": "1", "Minute": "36"}, {"Year": "2022", "Month": "6", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "25", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "6", "Day": "6"}], "PublicationStatus": "epublish", "ArticleIdList": ["35745507", "PMC9227457", "10.3390/pathogens11060653", "pathogens11060653"]}}], "PubmedBookArticle": []}